Apr 3, 2020, 16:24 by

Zymewire announces the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.

Apr 3, 2020, 16:24 by

Noxopharm has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.

Apr 3, 2020, 16:24 by

FHI Clinical just announced it has partnered with Seattle-based Infectious Disease Research Institute (IDRI) to provide full-service CRO capabilities for an immunotherapy trial to combat moderate to severe cases of COVID-19.

Apr 3, 2020, 16:24 by

Apr 3, 2020, 16:23 by

The release announces an update on the company’s business operations in response to and as a result of the global COVID-19 pandemic; one of the announcements includes the Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned dose level.

Apr 3, 2020, 09:46 by User Not Found

Clinical Research News Contributed Commentary | Although clinical trials are meant to cover global populations, the pool of patients currently enrolled in clinical trials is not representative of world populations. In order to broaden the recruitment of patients enrolled in clinical trials, clinical research opportunities in remote areas must be increased.

Apr 2, 2020, 09:31 by User Not Found

Clinical Research News | The reality of the novel coronavirus (COVID-19) has presented numerous challenges for society—and these challenges extend to clinical research as well.

Apr 1, 2020, 09:15 by User Not Found

Clinical Research News | The COVID-19 pandemic has left both pharmaceutical companies and researchers scrambling for continuity as clinical trials continue. Looking to create a concise resource to support teams continuing their work, Craig Lipset helped develop Coronatrials.org, a site for researchers to find support in trial continuity, ranging from remote medication adherence and remote clinical monitoring to decentralized trial technology providers.

Mar 31, 2020, 11:11 by User Not Found

Clinical Research News | March was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Veeva, Celsion, WCG, and more.

Mar 30, 2020, 10:39 by User Not Found

Clinical Research News | Growing appreciation in the research community about the impact of when we sleep, eat, and take our medicines has resulted in more interventional clinical trials aimed at correcting disturbances in the body’s complex of circadian clocks. It’s difficult work with potentially far-reaching implications for everything from losing weight and preventing preterm births to treating diabetes and prolonging survival from devastating cancers.

Mar 27, 2020, 13:29 by

The initiative launches with a weekly webinar series featuring WCG experts and guest panelists, with a focus on communicating emerging best practices in real time.

Mar 27, 2020, 11:16 by User Not Found

Clinical Research News | Over the past decade, digital marketplaces have emerged as a transformative business model. It’s time to reinvent the expensive, inefficient and biased clinical trial process; maybe marketplaces are the answer.

Mar 26, 2020, 13:39 by User Not Found

Clinical Research News | The large-scale Malaria Vaccine Implementation Programme (MVIP) of the World Health Organization (WHO) has ignited debate within the bioethics community about whether it is really a cluster randomization study that has seriously breached international ethical standards by failing to obtain informed consent from the parents of children opting for vaccination.

Mar 26, 2020, 09:14 by User Not Found

Clinical Research News Contributed Commentary | In recent years, several pharmaceutical companies have shifted their research and development to target personalized medicines including novel cell and gene therapies, many of which offer the prospect of first-time treatments and even curative benefit for patients. While these therapies represent important and historic advances in medicine, they also require regulators, healthcare providers (HCPs), payers, and manufacturers to consider new value-based care principles and payment models to enable their commercialization and affordability.

Mar 25, 2020, 09:53 by User Not Found

Clinical Research News | People who have erratic schedules seem to suffer more with many diseases, including certain cancers, and women with irregular sleep-wake patterns are also at heightened risk for preterm birth, says Erik Herzog, a neuroscientist and professor at Washington University as well as president of the Society for Research on Biological Rhythms (SRBR). Working with OB-GYN researchers at Washington University, his lab found similar and reliable changes in the daily rhythms of both women and mice during pregnancy.

Mar 24, 2020, 15:04 by User Not Found

Clinical Research News | Circadian medicine gained newfound attention in 2017 when three scientists were awarded the Nobel Prize in Physiology and Medicine for their discovery of the molecular mechanisms controlling how time is measured in biological systems. But the backstory on the field goes back decades, including the 1997 discovery and cloning of the first circadian clock gene in mammals.

Mar 24, 2020, 10:30 by User Not Found

Clinical Research News | A group of doctors from Stanford University has proposed a framework for sharing clinical data for artificial intelligence (AI) that could set off a firestorm of debate about who truly owns medical data, ethical obligations to share it, and how to properly police researchers who use it. On the other hand, the envisioned approach has parallels to the open science tactics currently being uniformly deployed to battle the COVID-19 pandemic.

Mar 23, 2020, 15:27 by

CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing Coronavirus outbreak.

Mar 23, 2020, 15:27 by

Mar 23, 2020, 15:27 by

Creative Diagnostics launches high-quality plant pathogens antibodies for use in ELISA or related immunoassays.